The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Khan Najat since 2025.
This trader's CIK number is 2020969.
At the time of last reporting, Khan Najat was the Chief R&D Commercial Officer of Recursion Pharmaceuticals, Inc.. (stock ticker symbol RXRX).
Also see all insider trading activities at Recursion Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RXRX | 0 | $0 | 36,599 | $202,172 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-18 | RXRX | Sale | 36,599 | 5.52 | 202,172 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Khan Najat (Chief R&D Commercial Officer of Recursion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.